6.1 Antiretroviral therapy is recommended for all patients with HIV and drug-resistant TB requiring second-line anti-TB drugs, irrespective of CD4 cell count, as early as possible (within the first 8 weeks) following initiation of anti-TB treatment(Strong recommendation, very low quality evidence)(No change). This evidence concerns the gene CD4 and tuberculosis.